Some senior living operators add vaccine access to marketing toolkits to help rebuild occupancy
By
Kimberly Bonvissuto
Jan 25, 2021
As the COVID-19 pandemic sends occupancy rates plummeting in senior living communities, some operators are adding vaccine access to their marketing toolbox in a bid to entice prospective residents and...
Fourth dose of BNT162b2 prevents severe COVID-19 in nursing home residents
Jun 27, 2022
Substantial protection against hospitalizations and deaths seen among nursing home residents during the omicron surge.
In 11 states, seniors’ low vaccination rates a ‘powder keg’ for new cases
Jun 21, 2021
In states where vaccination rates are low, seniors who have not gotten a shot pose a public health risk as social-distancing restrictions are stripped away.
COVID-19 vaccine booster dose cuts infection in those 60 and older
Sep 17, 2021
A large Israeli study shows a reduction in confirmed infection and severe illness among adults 60 years of age and older.
Ventas portfolio sees 5 consecutive months of occupancy growth: CEO
By
Kimberly Bonvissuto
Aug 09, 2021
Ventas Chairman and CEO Debra Cafaro said Friday that she sees a clear path to growth for the Chicago-based real estate investment trust and is committed to “winning the recovery.”
Pfizer has two updated booster shots to help fight omicron
Jun 27, 2022
The company said Saturday that it was confident that its new booster candidates are better than their predecessor.
Potential safety concern for Guillain-Barré syndrome ID’d for Ad26.COV2.S
Oct 18, 2021
Receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine is associated with a potential small, but statistically significant, safety concern for Guillain-Barré syndrome (GBS), according...
Holiday announces COVID shot mandate one day after full approval of Pfizer vaccine
By
Lois A. Bowers
Aug 25, 2021
The country’s largest independent living operator, Winter Park, FL-based Holiday Retirement, is requiring its more than 6,300 employees to receive their first COVID-19 vaccine by Oct. 4, the company...
Pfizer study reveals big rise in immunity from COVID-19 booster
Nov 04, 2022
The FDA says the findings affirm its decision to approve the booster without human testing based on experience with a similarly tweaked vaccine.
Third, fourth COVID-19 vaccine doses boost humoral response in seniors
Jul 27, 2022
Third and fourth doses were tied to significantly increased anti-S IgG titers in older adults, but optimal timing of additional doses is not known.